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Abstract 
Background Nowadays, increasingly more preemptive analgesia studies focus on post-
operative pain; however, the impact of preemptive analgesia on perioperative opioid 
requirement is not well defined. This study was carried out in order to evaluate whether 
preoperative intravenous flurbiprofen axetil can reduce perioperative opioid consump-
tion and provide postoperative analgesia in patients undergoing thyroid gland surgery. 
Methods Ninety patients undergoing elective thyroid gland surgery were randomly as-
signed to three groups. Group A (Control) was administered Intralipid® 2 ml as a placebo 
15 min before the cervical plexus block and at the end of the surgery; Group B (Routine 
analgesia)  was  administered  a  placebo  15  min  before  the  cervical  plexus  block  and 
flurbiprofen 50 mg at the end of the surgery; Group C (Preemptive analgesia) was ad-
ministered intravenous flurbiprofen 50 mg 15 min before the cervical plexus block and a 
placebo at the end of the surgery. Sufentanil administration during the surgery and the 
24 h satisfaction score on analgesic therapy were both recorded. The analgesic efficacy 
was assessed at 1, 2, 4, 6, 8, 12, and 24 hours after the surgery, based on visual analog 
scales. 
Results Ninety patients were involved in the study. One patient from Group B did not 
have their scheduled surgery; eighty-nine patients completed the study. There were no 
significant differences in the patient demographics between the three groups. Visual an-
alog scales: 1, 2, 4 h for Group A was significantly higher than Groups B and C (P<0.05); 
Sufentanil administration during surgery: Group C was obviously lower compared to 
Groups A and B (P<0.05); 24 h satisfaction score: Groups B and C were higher than 
Group A (P<0.05). 
Conclusion Preoperative administration of intravenous Flurbiprofen axetil reduced an-
algesic consumption during surgery, but not postoperative pain scores. 
Key  words:  preemptive  analgesia;  Flurbiprofen;  thyroid  gland  surgery;  cervial  plexum  block; 
postoperative pain. 
Introduction 
Preemptive analgesia is the administration of an 
analgesic before a painful stimulus that prevents the 
establishment  of  the  altered  processing  of  afferent 
input, which amplifies postoperative pain; and effec-
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tive preemptive analgesia should prevent the estab-
lishment of central sensitization caused by incisional 
and inflammatory injuries (covers the period of sur-
gery  and  the  initial  postoperative  period).1  Experi-
mental  evidences  suggest  that  better  postoperative 
analgesia in patients receiving the analgesic preoper-
atively compared to those patients, who were treated 
postoperatively.2-4 Except postoperative pain, periop-
erative analgesic consumption may be another index 
of preemptive analgesia, because it can indicate pe-
ripheral and central sensitization during surgery in-
directly  and  it  has  a  direct  effect  on  postoperative 
pain.  Unfortunately,  perioperative  analgesic  con-
sumption  was  ignored  in  preemptive  analgesia  re-
search. Maybe, that is one of the reasons that some 
preemptive  analgesia  research  reached  negative 
findings.5,6  
Flurbiprofen axetil (FA) is an injectable nonse-
lective COX inhibitor, with a high affinity to inflam-
matory tissues because of composed emulsified lipid 
microspheres.7,8 Preoperative intravenous administra-
tion of flurbiprofen reduces postoperative pain after 
tonsillectomy,  spinal  fusion  surgery,  hysterectomy, 
and  arthroscopic  rotator  cuff  repair  surgery.9-12 
However,  there  are  a  few  reports  on  whether  pre-
operative  FA  can  reduce  perioperative  opioid  con-
sumption and postoperative pain after thyroid gland 
surgery. In this study, the hypothesis that preopera-
tive administration FA reduces perioperative opioid 
consumption  and  provides  postoperative  analgesia 
for  patients  undergoing  thyroid  gland  surgery,  as 
compared  with  postoperative  administration  FA  or 
placebo was tested.  
Methods 
This  prospective,  double-blind,  randomized 
study was approved by the Ethics Committee of the 
Harbin Medical University and informed consent was 
obtained from the patients prior to study enrollment. 
Ninety  patients  undergoing  elective  thyroid  gland 
surgery were involved in this study. 
The  inclusion  criteria  were:  1)  ASA  physical 
status  I  or  II  patients  undergoing  elective  thyroid 
surgery;  2)  aged  30–60  years.  The  exclusion  criteria 
were: 1) patients who had received nonsteroidal an-
ti-inflammatory  drugs  (NSAIDs),  opioid  or  drugs 
with known analgesic properties in the 24 h before 
surgery; 2) patients with a history of allergic reaction 
to local anesthetics, opioid, NSAIDs; 3) patients with 
any contraindications for the use of NSAIDs, such as: 
gastrointestinal  ulcer,  coagulation  disorders,  renal 
dysfunction, heart failure and ischemic heart disease; 
4) patients unable to comprehend the concept of the 
visual  analog  pain  scale  (VAS).  All  of  the  patients 
were  instructed  the  day  before  surgery  about  the 
study protocol and particularly about the use of VAS. 
No  premedication  was  given,  and  all  the  patients 
fasted from midnight before surgery. 
On  arrival  at  the  operating  room,  patients  re-
ceived 2–3 mg intravenous midazolam. The standard 
monitors,  including  pulse  oximetry,  electrocardiog-
raphy, and noninvasive arterial blood pressure, were 
applied.  Patients  were  randomized  to  treatment 
groups  A  (Control),  B  (Routine  analgesia),  or  C 
(Preemptive analgesia) in a sequence generated by a 
computerized random number generator and sealed 
in numbered, opaque envelopes. The envelopes con-
tained two 5-mL syringes, labeled ―pre‖ and ―post,‖ 
with the contents blinded to anesthesiology, surgeons, 
operating  room  staff,  recovery  room  staff,  and  the 
patient  until  the  study  was  completed.  Group  A 
(Control) received Intralipid® 2 ml as a placebo 15 min 
before the cervical plexus block and at the end of the 
surgery; Group B (Routine analgesia) received a pla-
cebo 15 min before cervical plexus block and flurbi-
profen axetil 50 mg (2ml) at the end of surgery; Group 
C  (Preemptive  analgesia)  received  intravenous 
flurbiprofen axetil 50 mg 15 min before the cervical 
plexus block and a placebo at the end of the surgery.  
Bilateral combined superficial and deep cervical 
plexus block with 0.5% ropivacaine was given in all 
the cases. A deep cervical plexus block was performed 
by using a 23-gauge, short beveled needle (Pole, Top, 
Japan). It was inserted behind the lateral border of the 
sternocleidomastoid muscle, 3 cm distal to the mas-
toid process. After negative aspiration for blood, 8 mL 
of solution was  injected. The same needle  was also 
used in a superficial cervical plexus block, and it was 
inserted  at  the  midpoint  of  the  sternocleidomastoid 
muscle, corresponding to the C3 transverse apophy-
sis. After negative aspiration for blood in three direc-
tions,  4.5  mL  of  the  solution  was  injected  up  and 
down at the posterior border of the sternocleidomas-
toid muscle to block the occipital, auricular, and su-
praclavicular  branches  of  the  superficial  cervical 
plexus and 1.5 mL was injected horizontally above the 
muscle to block the transverse cervical nerve. Mean 
arterial blood pressure was maintained within 20% of 
the  baseline  values,  in  which  additional  boluses 
sufentanil were given in incremental doses of 1–2μg 
when  necessary.  All  surgical  and  anesthetic  proce-
dures were performed by the same teams. 
Postoperative pain management was standard-
ized  as  follows:  For  postoperative  pain  relief,  tra-
madol was administered in increments of 50 mg on 
patient  demand  with  a  lock-out  time  of  4  h  and  a 
maximum dose of 300mg/day. One ward nurse, who 
was  blinded  to  group  allocation,  documented  the Int. J. Med. Sci. 2011, 8 
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postoperative  pain  intensity  using  VAS  at  the  first 
rescue analgesics request, and at 1, 2, 4, 6, 8, 12, and 24 
hours after surgery at rest. The time to the first request 
and the number of times tramadol was used in the 
first 24 hours after surgery were recorded. If the pa-
tients experienced severe nausea and vomiting, 10 mg 
metoclopramide  iv  was  administered.  Sufentanil 
consumption during surgery and 24 h 4-point rating 
scale satisfaction score (0 very unsatisfied, 1 unsatis-
fied, 2 satisfied, 3 very satisfied) on analgesic therapy 
were both recorded blindly by one of the authors. Side 
effects  related  to  the  regional  anesthetic  technique, 
such as cervical epidural analgesia and diaphragmatic 
palsy, were recorded. Particularly, patients were clin-
ically  evaluated  by  an  experienced  anesthesiologist 
for respiratory distress related to bilateral diaphrag-
matic palsy at recovery and in the PACU. Should this 
occur, dynamic chest radiograph examination would 
be performed to ascertain the diagnosis. Other side 
effects associated with flurbiprofen, such as vomiting 
and antiemetic requirements, were recorded. 
Statistical analyses were performed using a sta-
tistical software package (SPSS13.0, Chicago, IL). Data 
were analyzed by the analysis of variance (ANOVA) 
with repeated measures, using one dependent varia-
ble on the time course. Analysis of the categorical data 
and proportions was performed using the χ2 test. The 
differences between the two groups were evaluated 
using the Student t test, Mann-Whitney rank sum test, 
and Fisher exact test, where appropriate. P<0.05 was 
considered significant. The sample size was calculated 
to detect a difference of 2.0 in pain intensity on a vis-
ual analogue scale (VAS 0-10). Based on the assump-
tion of a standard deviation of 2.0, we  calculated a 
sample  size  of  20  patients  per  group.  This  number 
would  be  sufficient  to  find  the  mentioned  clinical 
endpoint with a power of 0.89 as statistically signifi-
cant.  
 
Results 
Ninety patients were involved in the study. One 
patient from the group B did not have her scheduled 
surgery;  eighty-nine  patients  completed  the  study. 
The  demographic  characteristics  and  intraoperative 
data  of  the  three  groups  are  presented  in  Table  1. 
There  were  no  significant  differences  in  the  patient 
demographics between the three groups. In addition, 
pulse  oximetry,  heart  rates,  blood  pressures,  blood 
loss,  and  fluid  administration  during  surgery  were 
not statistically different between the groups (P>0.05).  
 
 
Table 1. Characteristics of the Patients 
 
Variable 
Control 
(n =30) 
Routine anal-
gesia 
(n =29) 
Preemptive anal-
gesia 
(n =30) 
Gender (M/F)  18/12  16/13  17/13 
Age (yrs)  47.43 ± 6.35  49.80 ± 7.24  47.93 ± 6.94 
Weight (kg)  59.73 ± 6.32  62.45 ± 7.28  59.84 ± 7.50 
Height (cm)  174 ± 8  172 ± 6  171 ± 6 
Duration of sur-
gery (min) 
87.38 ± 
22.75 
90.32 ± 24.87  89.35 ± 23.28 
There were no significant differences between the demographic 
variables for the groups. Data are mean ± SD or n. 
 
 
 
VAS data are presented in Fig. 1. VAS in group B 
and C were significantly lower than that in group A at 
1, 2, 4 h after surgery (P<0.05). There were no differ-
ences in VAS between Groups A, B and C at 6, 8, 12, 24 
h after surgery (P>0.05). The number of patients who 
need additional postoperative analgesia in Group A is 
more than Groups B and C (P<0.05) (Fig. 2). 
Sufentanil consumption during surgery are pre-
sented in Fig. 3, in which sufentanil consumption in 
group  C  (3.68  ±  1.20μg)  was  obviously  lower  com-
pared  to  Groups  A  (6.40  ±  1.66μg)  and  B  (7.21  ± 
1.95μg) (P<0.05). 
Patients  evaluated  the  overall  quality  of  their 
postoperative analgesia in the recovery process using 
the 24 h satisfaction score, both Group B (1.82 ± 1.03) 
and Group C (1.75 ± 0.89) were higher than Group A 
(0.85 ± 0.93)(P<0.05) (Fig. 4). 
No patient showed any adverse effect associated 
with FA and there were no surgical complications. 
 
 
Figure 1. Visual analog pain scale, patients rated their 
levels of pain on the 0–10 cmVAS (0 cm = no pain to 10 cm 
= the worst possible pain). 
* P<0.05 Preemptive analgesia 
and routine analgesia group versus the control group. Int. J. Med. Sci. 2011, 8 
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Figure 2. The ratios of people need additional postop-
erative  analgesia. 
*  P<0.05  Preemptive  analgesia  and 
routine analgesia group versus the control group. 
 
 
 
Figure 3. Sufentanil consumption during surgery.             
* 
P<0.05, Preemptive analgesia group versus the control 
group;
 †P<0.05 Preemptive analgesia group versus rou-
tine analgesia group. 
 
 
 
Figure  4.  24h satisfaction score, patients rated their 
levels of analgesic satisfaction on the 0-4score (0 very 
unsatisfied, 1 unsatisfied, 2 satisfied, 3 very satisfied).  
* 
P<0.05  Preemptive  analgesia  and  routine  analgesia 
group versus the control group. 
 
Discussion 
The present results indicate that preoperative FA 
provides less sufentanil consumption during surgery, 
better immediate postoperative analgesia than place-
bo. But, compared to patients receiving FA at the end 
of surgery, there is lack of preemptive analgesia effect.  
In animal experiments, the validity of preemp-
tive analgesia has been demonstrated.13,14 Neverthe-
less, some clinical studies have conflicting results re-
garding  the  efficacy  of  preemptive  analgesia.15-17  A 
meta-analysis published in 2002 showed that there is 
no conclusive clinical evidence to support preemptive 
analgesia.18  However,  another  meta-analysis  pub-
lished in 2005 has shown that preemptive local anes-
thetic  wound  infiltration  and  nonsteroidal  an-
ti-inflammatory  drug  (NSAID)  administration  im-
proved  analgesic  consumption  and  the  time  to  the 
first  rescue  analgesic  request,  but  not  postoperative 
pain scores.19  
Some authors have suggested that the effects of 
preemptive analgesia may vary according to the type 
of  surgery.20  Whether  preemptive  analgesia  can  be 
effective depends on the prevention of the establish-
ment  of central sensitization. In some kinds  of  sur-
gery, such as fracture, spinal disc herniation, appen-
dicitis, and acute or chronic pain already exist. Under 
these  clinical  conditions,  we  can  easily  notice  that 
central sensitization has already been established by 
presurgical pain.21 To avoid this condition, we chose 
thyroid gland surgery, which is not to be studied in 
preemptive  analgesia  research  and  there  is  no  pre-
surgical pain. 
In  general,  general  anesthesia  is  more  suitable 
for thyroid gland surgery. In this study, we carried 
out a bilateral combined superficial and deep cervical 
plexus block. The most important reason is that we 
wanted to compare the preemptive analgesia effect on 
sufentanil consumption during surgery. Perioperative 
analgesic consumption may be another index except 
postoperative pain, because it can indicate periphery 
and central sensitization during surgery and it has a 
direct  effect  on  postoperative  pain.22  Unfortunately, 
most studies ignore this factor. The present study in-
dicated that preemptive FA resulted in less sufentanil 
consumption during surgery than postoperation FA, 
which  is  maybe  the  result  of  the  prevention  of  the 
establishment of central sensitization. The reason why 
there was no difference in VAS of postoperation be-
tween Groups B and C may ascribe the difference in 
sufentanil consumption during surgery.  
There  are  two  phases  -  incisional  and  inflam-
matory  (reaction  to  the  damaged  tissue)  -  in  sur-
gery-induced central sensitization. It is suggested that Int. J. Med. Sci. 2011, 8 
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as inflammatory injury plays dominant role, antino-
ciceptive  protection  provided  by  preemptive  treat-
ment should extend into the postoperative period to 
cover the inflammatory phase; otherwise, it is ineffec-
tive as in the rat paw incisional model.1 The analgesic 
effect of FA would begin 30 min after administration, 
with an elimination half-life of 6 h.12 We administered 
FA 15 min before a cervical plexus block in order to 
make sure that the analgesic effect of FA before the 
incision  and  lasted  throughout  the  operation.  The 
analgesic properties of FA can be attributed to their 
inhibition  of  COX  and  the  subsequent  decrease  in 
prostaglandins in the periphery.23  
A  nerve  block  is  one  of  the  modalities  of 
preemptive  analgesia  studied.24  All  patients  in  the 
present study, irrespective of the group assignment, 
received  a  cervical  plexus  block  before  surgery. 
Probably due to this treatment, the mean pain score 
was never above 6 (Fig.1). However, the present study 
did not compare the efficacy of a cervical plexus block 
as a preventive analgesia and studied only the possi-
ble benefits of FA. 
The NSAIDs are associated with many adverse 
effects, including reducing platelet aggregation, renal 
and gastrointestinal mucosal injury. However, in this 
study,  there  was  no  difference  of  intraoperative  or 
postoperative  blood  losses  between  three  groups. 
Also, no adverse effects on renal and gastrointestinal 
mucosal injury were found in any of the patients. That 
may be because of the only single dose infusion. These 
results are similar to other studies9-11.  
There  are  several  limitations  of  the  present 
study.  Cervical  plexus  block  may  influence  the  re-
sults.  Psychosocial  characteristics,  educational  back-
ground  and  preoperative  pathology  of  the  patients 
were not controlled in this study.  
In  conclusion,  preoperative  administration  of 
intravenous  flurbiprofen  axetil  reduced  analgesic 
consumption during thyroid gland surgery, but not 
postoperative pain scores. 
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